ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2007

Disturbances of the Acral Perfusion Detected By Fluorescence Optical Imaging Are Associated with the Development of Ischemic Complications in Patients with Systemic Sclerosis

Stefanie Friedrich1,2, Susanne Lueders3, Stephanie Werner3,4, Anne-Marie Glimm5, Gabriela Schmittat5, Gerd R. Burmester6, Gabriela Riemekasten7, Marina Backhaus8 and Sarah Ohrndorf9, 1Department of of Rheumatology and Clinical Immunology, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; Germany, Berlin, Germany, 2Department of Radiology, Department of Radiology, Charité University Hospital, Berlin; Germany, Berlin, Germany, 3Department of Rheumatology and Clinical Immunology, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; Germany, Berlin, Germany, 4Department of Rheumatology, Helios St. Johannes Clinic, Duisburg, Germany, 5Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany, 6Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Free University and Humboldt University Berlin, Berlin, Germany, 7Department of Rheumatology, Universitatsklinikum Schleswig-Holstein, Lubeck, Germany, 8Rheumatology, Park-Klinik Weissensee, Berlin, Germany, 9Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Capillaroscopy, imaging techniques, risk, systemic sclerosis and ulcers

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Imaging of Rheumatic Diseases Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Systemic sclerosis (SSc) is a condition causing impaired microcirculation with the risk of ischemic complications such as digital ulcers and pitting scars (DU/PS). Fluorescence optical imaging (FOI) is an imaging method that detects enhanced microcirculation as a sign of joint inflammation in both hands of patients with rheumatoid arthritis and other arthritides [1, 2]. FOI’s impact to record disturbed microcirculation in the hands of patients with systemic sclerosis has not yet been sufficiently investigated [3]. The aim of this study is to find associations of disturbed microcirculation initially detected by FOI and the development of new DU/PS throughout a follow-up of 12 months.

Methods:

Sixty-three patients with SSc were included and received FOI examination following the Xiralite-System guidelines (ICG 0.1mg/kg BW i.v.; 6 minute duration) as well as capillaroscopy at baseline. After a mean follow-up time of 12 months (min-max: 8-20 months), all participants were followed regarding the development of new ulcers and pitting scars.

Results:

A disruption of microcirculation in FOI was defined as a lack of a sufficient fluorescent signal in at least one fingertip over the entire course of the examination and was found in 11 of 63 SSc patients. All of these patients had a history of DU/PS and frequently presented with a late pattern capillaroscopy (9 of 11) at baseline. Fingers with a disrupted microcirculation also showed a reduced capillary density to a greater extend (96.0%) than fingers with a sufficient signal in FOI (76.0%; p=0.0241).

30 of 60 patients developed digital ulcers or pitting scars during follow up (3 drop outs due to death [n=2] or withdrawal). 81.8% of patients with a disturbed microcirculation in FOI developed these complications during follow-up compared with 42.9% of patients without a disruption in FOI (p=0.0419; OR=6.0 [95%CI 1.2 – 30.7]). A disruption of microcirculation especially increased the risk of developing DU/PS in the same finger: 20.1% of fingers with normal, but 65.4% with a missing FOI signal in the fingertip presented with an ischemic complication during follow-up (p<0.0001; OR=7.5 [95%CI 3.3 – 17.3]).

Conclusion:

Fluorescence optical imaging can reveal an impaired microcirculation in patients with systemic sclerosis, which is associated with microangiopathic changes as seen in capillaroscopy as well as the subsequent development of digital ulcers and pitting scars. Therefore, FOI might help to identify patients at risk for these complications.


Disclosure: S. Friedrich, None; S. Lueders, None; S. Werner, None; A. M. Glimm, None; G. Schmittat, None; G. R. Burmester, AbbVie, BMS, MSD, Pfizer, Roche, and UCB, 5; G. Riemekasten, CellTrend, 4; M. Backhaus, None; S. Ohrndorf, None.

To cite this abstract in AMA style:

Friedrich S, Lueders S, Werner S, Glimm AM, Schmittat G, Burmester GR, Riemekasten G, Backhaus M, Ohrndorf S. Disturbances of the Acral Perfusion Detected By Fluorescence Optical Imaging Are Associated with the Development of Ischemic Complications in Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/disturbances-of-the-acral-perfusion-detected-by-fluorescence-optical-imaging-are-associated-with-the-development-of-ischemic-complications-in-patients-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disturbances-of-the-acral-perfusion-detected-by-fluorescence-optical-imaging-are-associated-with-the-development-of-ischemic-complications-in-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology